Effect of glucuronidation substrates/inhibitors on N-(3,5-dichlorophenyl)succinimidenephrotoxicity in Fischer 344 rats

Toxicology

Volumn 132, Issue 1, 1999, Pages 43-55

  Hong, Suk K ^a   Anestis, Dianne K ^a   Brown, Patrick I ^a   Rankin, Gary O ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fungicides; Glucuronidation; Nephrotoxicity; Rats; Succinimides

Indexed keywords

BORNEOL; CLOFIBRATE; EUGENOL; FUNGICIDE; N (3,5 DICHLOROPHENYL)SUCCINIMIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG STRUCTURE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BIOTRANSFORMATION; BLOOD UREA NITROGEN; BORNANES; CLOFIBRIC ACID; DRINKING; EATING; EUGENOL; FUNGICIDES, INDUSTRIAL; GLUCURONATES; KIDNEY; KIDNEY DISEASES; MALE; ORGAN SIZE; P-AMINOHIPPURIC ACID; PROTEINURIA; RATS; RATS, INBRED F344; SUCCINIMIDES; TETRAETHYLAMMONIUM COMPOUNDS; VALPROIC ACID;

SESAMUM INDICUM;

EID: 0032944115     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00140-1     Document Type: Article

References (64)

1. Aleo M.D., Rankin G.O., Cross T.J., Schnellmann R.G. Toxicity of N-(3,5-dichlorophenyl)succinimide and metabolites to rat renal proximal tubules and mitochondria. Chem. Biol. Interact. 78:1991;109-121.
2. Baldwin J.R., Witiak D.T., Feller D.R. Disposition of clofibrate in the rat, acute and chronic administration. Biochem. Pharmacol. 29:1980;3143-3154.
3. Barrett M.C., Cashman S.J., Moss J. Experimental interstitial renal fibrosis in rats: nephritis induced by N-(3,5-dichlorophenyl)succinimide. Br. J. Exp. Pathol. 64:1983;425-435.
4. Beers K.W., Nicoll D.W., Anestis D.K., Brown P.I., Rankin G.O. Effect of microsomal enzyme modulators on N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS)-induced nephrotoxicity in the Fischer 344 rat. Toxicology. 84:1993;141-155.
5. Beers K.W., Rankin G.O. Effect of N-(3,5-dichlorophenyl)-2-hydroxysuccinimide on renal function and hemodynamics in the anesthetized rat. Toxicology. 79:1993;139-148.
6. Bock K.W., Frohling W., Remmer H., Rexer B. Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta. 327:1973;46-56.
7. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
8. Dickinson R.G., Kluck R.M., Wood B.T., Eadie M.J., Hooper W.D. Impaired biliary elimination of β-glucuronidase-resistant 'Glucuronides' of valproic acid after intravenous administration in the rat: evidence for oxidative metabolism of the resistant isomers. Drug Metab. Disp. 14:1986;255-262.
9. Dickinson R.G., Verbeeck R.K., King A.R. Absence of phenolic glucuronidation and enhanced hydroxylation of diflunisal in the homozygous Gunn rat. Xenobiotica. 21:1991;1535-1546.
10. Fournel-Gigleux S., Hamar-Hansen C., Motassim N., Antoine B., Mothe O., Decolin D., Caldwell J., Siest G. Substrate specificity and enantioselectivity of arylcarboxylic acid glucuronidation. Drug Metab. Disp. 16:1988;627-634.
11. Fujinami A., Ozaki T., Yamamoto S. Studies on biological activity of cyclic imide compounds. Part I. antimicrobial activity of 3-phenyloxazolidine-2,4-diones and related compounds. Agric. Biol. Chem. 35:1971;1707-1719.
12. Fujinami A., Ozaki T., Nodera K., Tanaka K. Studies on biological activity of cyclic imide compounds. Part II. antimicrobial activity of 1-phenylpyrrolidine-2,5-diones and related compounds. Agric. Biol. Chem. 36:1972;318-323.
13. Goon D., Klaassen C.D. Effects of microsomal enzyme inducers upon UDP-glucuronic acid concentration and UDP-glucuronosyltransferase activity in the rat intestine and liver. Toxicol. Appl. Pharmacol. 115:1992;253-260.
14. Hansen-Moller J., Cornett C., Dalgaard L., Hansen S.H. Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. J. Pharmaceut. Biomed. Anal. 6:1988;229-240.
15. Harvison P.J., Griffith R.J., Teets V.J., Nicoll D.W., Brown P.I., Rankin G.O. Nephrotoxic potential of N-(3,5-dichloro-4-hydroxyphenyl)succinimide and N-(3,5-dichloro-4-hydroxyphenyl)succinamic acid in Fischer 344 rats. Toxicol. Lett. 60:1992;221-226.
16. Hasegawa J., Smith P.C., Benet L.Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metab. Disp. 10:1982;469-473.
17. Heaton J.B. Control of brown rot and transit rot of peaches with post-harvest fungicidal dips. Queensland J. Agric. Animal Sci. 37:1980;155-159.
18. Henesey C.M., Harvison P.J. Potential metabolism and cytotoxicity of N-(3,5-dichlorophenyl)succinimide and its hepatic metabolites in isolated rat renal cortical tubule cells. Toxicology. 104:1995;9-16.
19. Hong S.K., Anestis D.K., Ball J.G., Valentovic M.A., Rankin G.O. N-(3,5-Dichlorophenyl)succinimide (NDPS) and NDPS metabolite nephrotoxicity in Wistar rats. Toxicologist. 42:1998;376.
20. Howell S.R., Hazelton G.A., Klaassen C.D. Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated. J. Pharmacol. Exp. Ther. 236:1986;610-614.
21. Igarashi T., Irokawa N., Ono S., Ohmori S., Ueno K., Kitagawa H., Satoh T. Difference in the effects of phenobarbital and 3-methylcholanthrene treatment on subunit composition of hepatic glutathione S-transferase in male and female rats. Xenobiotica. 17:1987;127-137.
22. Ito N., Sugihara S., Makiura S., Arai M., Hirao K., Denda A., Nishio O. Effect of N-(3,5-dichlorophenyl)succinimide on the histological pattern and incidence of kidney tumors in rats. Gann. 65:1974;131-138.
23. Kretz-Rommel A., Boelsterili U.A. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 120:1993;155-161.
24. Krijgsheld K.R., Koster H.J., Scholtens E., Mulder G.J. The cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate. J. Pharmacol. Exp. Ther. 221:1982;731-734.
25. Lilienblum W., Walli A.K., Bock K.W. Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agents. Biochem. Pharmacol. 31:1982;907-913.
26. Magdalou J., Chajes V., Lafaurie C., Siest G. Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metab. Disp. 18:1990;692-697.
27. Manautou J.E., Hoivik D.J., Tveit A., Emeigh Hart S.G., Khairallah E.A., Cohen S.D. Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol. Appl. Pharmacol. 129:1994;252-263.
28. McGurk K.A., Remmel R.P., Hosagrahara V.P., Tosh D., Burchell B. Reactivity of mefenamic acid 1-O-acyl glucuronide with proteins in vitro and ex vivo. Drug Metab. Disp. 24:1996;842-849.
29. Mulder G.J. Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 32:1992;25-49.
30. Mulder G.J., Coughtrie M.W., Burchell B. Glucuronidation. Mulder G.J. , Conjugation Reactions in Drug Metabolism: An Integrated Approach. 1990;51-105 Taylor and Francis, London.
31. Mulder G.J., Hinson J.A., Gillette J.R. Generation of reactive metabolites of N-hydroxy-phenacetin by glucuronidation and sulfation. Biochem. Pharmacol. 26:1977;189-196.
32. Nyarko N., Harvison P.J. Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide (NDPS) by isolated rat hepatocytes. Drug Metab. Disp. 23:1995;107-112.
33. Ohkawa H., Hisada Y., Fujiwara N., Miyamoto J. Metabolism of N-(3′,5′-dichlorophenyl)succinimide in rats and dogs. Agric. Biol. Chem. 38:1974;1359-1369.
34. Pickett C.B., Telakowski-Hopkins C.A., Ding G.J.-F., Argenbright L., Lu A.Y.-H. Rat liver glutathione S-transferases: Complete nucleotide sequence of a glutathione S-transferase mRNA and the regulation of the Ya, Yb, and Yc mRNAs by 3-methylcholanthrene and phenobarbital. J. Biol. Chem. 259:1984;5182-5188.
35. Prakash C., Soliman V. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Drug Metab. Disp. 25:1997;1288-1297.
36. Rankin G.O. Nephrotoxicity following acute administration of N-(3,5-dichlorophenyl)succinimide in Sprague-Dawley rats. Toxicology. 23:1982;21-31.
37. Rankin G.O., Cressey-Veneziano K., Brown P.I. Onset of and recovery from acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Sprague-Dawley rats. Toxicology. 30:1984;209-216.
38. Rankin G.O., Yang D.J., Cressey-Veneziano K., Brown P.I. N-(3,5-Dichlorophenyl)succinimide nephrotoxicity in the Fischer 344 rat. Toxicol. Lett. 24:1985;99-105.
39. Rankin G.O., Yang D.J., Teets V.J., Brown P.I. Deuterium isotope effect in acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity. Life Sci. 39:1986;1291-1299.
40. Rankin G.O., Yang D.J., Richmond C.D., Teets V.J., Wang R.T., Brown P.I. Effect of microsomal enzyme activity modulation on N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity. Toxicology. 45:1987a;269-289.
41. Rankin G.O., Yang D.J., Teets V.J., Lo H.H., Brown P.I. The effect of probenecid on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in the Fischer 344 rat. Toxicology. 44:1987b;181-192.
42. Rankin G.O., Shih H.C., Yang D.J., Richmond C.D., Teets V.J., Brown P.I. Nephrotoxicity of N-(3,5-dichlorophenyl)succinimide metabolites in vivo and in vitro. Toxicol. Appl. Pharmacol. 96:1988;405-416.
43. Rankin G.O., Teets V.J., Nicoll D.W., Brown P.I. Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats. Toxicol. Lett. 52:1990;91-100.
44. Rankin G.O., Shih H.C., Teets V.J., Yang D.J., Nicoll D.W., Brown P.I. N-(3,5-Dichlorophenyl)succinimide nephrotoxicity: evidence against the formation of nephrotoxic glutathione or cysteine conjugates. Toxicology. 68:1991a;307-325.
45. Rankin G.O., Teets V.J., Nicoll D.W., Brown P.I. Effect of buthionine sulfoximine on N-(3,5-dichlorophenyl)-2-hydroxysuccinimide and N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid nephrotoxicity. Toxicol. Lett. 57:1991b;297-308.
46. Rankin G.O., Hong S.K., Valentovic M.A., Anestis D.K., Dial L.D., Ball J.G. Effect of inhibitors of glucuronide conjugation on N-(3,5-dichlorophenyl)succinimide (NDPS) metabolite nephrotoxicity in Fischer 344 rats. ISSX Proc. 8:1995;183.
47. Rankin G.O., Hong S.K., Dial L.D., Anestis D.K. Effects of chloramphenicol, dehydroepiandrosterone (DHEA) and 2,6-dichloro-4-nitrophenol (DCNP) on N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS) nephrotoxicity. Toxicologist. 30:1996;303.
48. Rankin G.O., Hong S.K., Anestis D.K., Skaggs C., Ball J., Valentovic M.A. N-(3,5-Dichlorophenyl)succinimide (NDPS) and NDPS metabolite nephrotoxicity in Gunn rats. Toxicologist. 36:1997a;145.
49. Rankin G.O., Hong S.K., Valentovic M.A., Beers K.W., Anestis D.K., Nicoll D.W., Ball J.G., Brown P.I. Effects of sodium sulfate on acute N-(3,5-dichlorophenyl)succinimide (NDPS) nephrotoxicity in the Fischer 344 rat. Toxicology. 123:1997b;1-13.
50. Savina P.M., Brouwer K.L.R. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat. Drug Metab. Disp. 20:1992;496-501.
51. Shinohara Y., Arai M., Hirao K., Sugihara S., Nakanishi K., Tsunoda H., Ito N. Combination effect of citrinin and other chemicals on rat kidney tumorigenesis. Gann. 67:1976;147-155.
52. Shinohara Y., Miyata Y., Murasaki G., Nakanishi K., Takashi Y., Ito N. Effect of N-(3,5-dichlorophenyl)succinimide on the histological pattern and incidence of kidney tumors induced by streptozotocin in rats. Gann. 68:1977;397-404.
53. Smith C.L., Jollow D.J. Enhancement of acetaminophen-induced liver necrosis in hamsters by borneol. Pharmacologist. 19:1977;162.
54. Spahn-Langguth H., Benet L.Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24:1992;5-48.
55. Sugihara S., Shinohara Y., Miyata Y., Inoue K., Ito N. Pathologic analysis of chemical nephritis in rats induced by N-(3,5-dichlorophenyl)succinimide. Lab. Invest. 33:1975;219-230.
56. Takayama C., Fujinami A. Quantitative structure-activity relationships of antifungal N-phenylsuccinimides and N-phenyl-1,2-dimethylcyclopropanedicarboximides. Pestic. Biochem. Physiol. 12:1979;163-171.
57. Thompson D.C., Constantin-Teodosiu D., Moldeus P. Metabolism and cytotoxicity of eugenol in isolated rat hepatocytes. Chem. -Biol. Interact. 77:1991;137-147.
58. Tomlin, C., 1994. The Pesticide Manual: Incorporating The Agrochemicals Handbook, 10th Ed, British Crop Protection Council, The Bath Press, Bath, UK.
59. Vore M., Durham S., Yeh S., Ganguly T. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol 17′-β(β-D-glucuronide). Biochem. Pharmacol. 41:1991;431-437.
60. Vree T.B., Van den Biggelaar-Martea M., Van Ewijk-Beneken Kolmer E.W.J., Hekster Y.A. Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment. Pharm. World Sci. 15:1993;165-170.
61. Watkins J.B., Klaassen C.D. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat. J. Pharmacol. Exp. Ther. 220:1982;305-310.
62. Watkins J.B., Klaassen C.D. Chemically-induced alteration of UDP-glucuronic acid concentration in rat liver. Drug Metab. Disp. 11:1983;37-40.
63. Yang D.J., Richmond C.D., Teets V.J., Brown P.I., Rankin G.O. Effect of succinimide ring modification on N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Sprague-Dawley and Fischer 344 rats. Toxicology. 37:1985;65-77.
64. Yang D.J., Teets V.J., Bolton B., Brown P.I., Rankin G.O. Role of glutathione in acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Sprague-Dawley and Fischer 344 rats. Toxicology. 45:1987;25-44.